The positive correlation between the number of reps detailing a product and that product's sales is well known. And it's especially strong in Europe where, unlike the US, DTC advertising is prohibited and hence patients' influence on prescribing decisions is minimal.
But in a marketplace dominated by Big Pharma's huge sales forces, Europe's mid-sized companies, with fewer resources, are at a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?